Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Therapeutic Effect of Immunotherapy in Patients With Advanced Lung Squamous Carcinoma
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Summary
The aim of this observational study is to investigate the treatment trajectory of immunotherapy in patients with squamous non-small cell lung cancer (sq-NSCLC). The primary objective is to identify potential indicators that can predict the efficacy of immunotherapy and explore strategies to prolong its effectiveness in sq-NSCLC patients. Biological specimens and medical imaging data will be collected from patients already receiving immunotherapy as a first-line treatment, and follow-up will be conducted to analyze prognosis based on different patterns.
Official title: Exploration of the Treatment Trajectory and Drug Resistance Mechanism of Immunotherapy Combined With Chemotherapy in Patients With Advanced Lung Squamous Carcinoma
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2021-01-01
Completion Date
2027-12-31
Last Updated
2024-12-12
Healthy Volunteers
No
Conditions
Interventions
Efficacy observation
Observation about the efficacy of sq-NSCLC patients receiving immunotherapy combined with or without chemotherapy as first-line treatment.
Locations (1)
Union Hospital, Tongji Medical college, Huazhong University of Science and Technology
Wuhan, Hubei, China